Glucose Metabolism in Cancer and Ischemia

Possible Therapeutic Consequences of the Warburg Effect

Spela Salamon, Eva Podbregar, Peter Kubatka, Dietrich Busselberg, Martin Caprnda, Radka Opatrilova, Vanda Valentova, Mariusz Adamek, Peter Kruzliak, Matej Podbregar

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

The Warburg effect states that the main source of energy for cancer cells is not aerobic respiration, but glycolysis—even in normoxia. The shift from one to the other is governed by mutually counteracting enzymes: pyruvate dehydrogenase and pyruvate dehydrogenase kinase (PDK). Anaerobic metabolism of cancer cells promotes cell proliferation, local tissue immunosuppression, resistance to hypoxic conditions, and metastatic processes. By switching glucose back to oxidative metabolism, these effects might be reversed. This can be achieved using PDK inhibitors, such as dichloroacetate. Patients suffering from ischemic conditions might benefit from this effect. On the other hand, the β-blockers (adrenergic β-antagonists) often used in these patients appear to improve cancer-specific survival, and nonselective β-blockers have been shown to promote glucose oxidation. Might there be a link?

Original languageEnglish
Pages (from-to)177-183
Number of pages7
JournalNutrition and Cancer
Volume69
Issue number2
DOIs
Publication statusPublished - 17 Feb 2017

Fingerprint

Ischemia
Glucose
Anaerobiosis
Neoplasms
Adrenergic Antagonists
Pyruvic Acid
Immunosuppression
Oxidoreductases
Respiration
Therapeutics
Cell Proliferation
Survival
Enzymes
pyruvate dehydrogenase (acetyl-transferring) kinase

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Oncology
  • Nutrition and Dietetics
  • Cancer Research

Cite this

Glucose Metabolism in Cancer and Ischemia : Possible Therapeutic Consequences of the Warburg Effect. / Salamon, Spela; Podbregar, Eva; Kubatka, Peter; Busselberg, Dietrich; Caprnda, Martin; Opatrilova, Radka; Valentova, Vanda; Adamek, Mariusz; Kruzliak, Peter; Podbregar, Matej.

In: Nutrition and Cancer, Vol. 69, No. 2, 17.02.2017, p. 177-183.

Research output: Contribution to journalReview article

Salamon, S, Podbregar, E, Kubatka, P, Busselberg, D, Caprnda, M, Opatrilova, R, Valentova, V, Adamek, M, Kruzliak, P & Podbregar, M 2017, 'Glucose Metabolism in Cancer and Ischemia: Possible Therapeutic Consequences of the Warburg Effect', Nutrition and Cancer, vol. 69, no. 2, pp. 177-183. https://doi.org/10.1080/01635581.2017.1263751
Salamon, Spela ; Podbregar, Eva ; Kubatka, Peter ; Busselberg, Dietrich ; Caprnda, Martin ; Opatrilova, Radka ; Valentova, Vanda ; Adamek, Mariusz ; Kruzliak, Peter ; Podbregar, Matej. / Glucose Metabolism in Cancer and Ischemia : Possible Therapeutic Consequences of the Warburg Effect. In: Nutrition and Cancer. 2017 ; Vol. 69, No. 2. pp. 177-183.
@article{5a88eb431cdd4acf887c84f1cf7ddc1a,
title = "Glucose Metabolism in Cancer and Ischemia: Possible Therapeutic Consequences of the Warburg Effect",
abstract = "The Warburg effect states that the main source of energy for cancer cells is not aerobic respiration, but glycolysis—even in normoxia. The shift from one to the other is governed by mutually counteracting enzymes: pyruvate dehydrogenase and pyruvate dehydrogenase kinase (PDK). Anaerobic metabolism of cancer cells promotes cell proliferation, local tissue immunosuppression, resistance to hypoxic conditions, and metastatic processes. By switching glucose back to oxidative metabolism, these effects might be reversed. This can be achieved using PDK inhibitors, such as dichloroacetate. Patients suffering from ischemic conditions might benefit from this effect. On the other hand, the β-blockers (adrenergic β-antagonists) often used in these patients appear to improve cancer-specific survival, and nonselective β-blockers have been shown to promote glucose oxidation. Might there be a link?",
author = "Spela Salamon and Eva Podbregar and Peter Kubatka and Dietrich Busselberg and Martin Caprnda and Radka Opatrilova and Vanda Valentova and Mariusz Adamek and Peter Kruzliak and Matej Podbregar",
year = "2017",
month = "2",
day = "17",
doi = "10.1080/01635581.2017.1263751",
language = "English",
volume = "69",
pages = "177--183",
journal = "Nutrition and Cancer",
issn = "0163-5581",
publisher = "Routledge",
number = "2",

}

TY - JOUR

T1 - Glucose Metabolism in Cancer and Ischemia

T2 - Possible Therapeutic Consequences of the Warburg Effect

AU - Salamon, Spela

AU - Podbregar, Eva

AU - Kubatka, Peter

AU - Busselberg, Dietrich

AU - Caprnda, Martin

AU - Opatrilova, Radka

AU - Valentova, Vanda

AU - Adamek, Mariusz

AU - Kruzliak, Peter

AU - Podbregar, Matej

PY - 2017/2/17

Y1 - 2017/2/17

N2 - The Warburg effect states that the main source of energy for cancer cells is not aerobic respiration, but glycolysis—even in normoxia. The shift from one to the other is governed by mutually counteracting enzymes: pyruvate dehydrogenase and pyruvate dehydrogenase kinase (PDK). Anaerobic metabolism of cancer cells promotes cell proliferation, local tissue immunosuppression, resistance to hypoxic conditions, and metastatic processes. By switching glucose back to oxidative metabolism, these effects might be reversed. This can be achieved using PDK inhibitors, such as dichloroacetate. Patients suffering from ischemic conditions might benefit from this effect. On the other hand, the β-blockers (adrenergic β-antagonists) often used in these patients appear to improve cancer-specific survival, and nonselective β-blockers have been shown to promote glucose oxidation. Might there be a link?

AB - The Warburg effect states that the main source of energy for cancer cells is not aerobic respiration, but glycolysis—even in normoxia. The shift from one to the other is governed by mutually counteracting enzymes: pyruvate dehydrogenase and pyruvate dehydrogenase kinase (PDK). Anaerobic metabolism of cancer cells promotes cell proliferation, local tissue immunosuppression, resistance to hypoxic conditions, and metastatic processes. By switching glucose back to oxidative metabolism, these effects might be reversed. This can be achieved using PDK inhibitors, such as dichloroacetate. Patients suffering from ischemic conditions might benefit from this effect. On the other hand, the β-blockers (adrenergic β-antagonists) often used in these patients appear to improve cancer-specific survival, and nonselective β-blockers have been shown to promote glucose oxidation. Might there be a link?

UR - http://www.scopus.com/inward/record.url?scp=85010749137&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010749137&partnerID=8YFLogxK

U2 - 10.1080/01635581.2017.1263751

DO - 10.1080/01635581.2017.1263751

M3 - Review article

VL - 69

SP - 177

EP - 183

JO - Nutrition and Cancer

JF - Nutrition and Cancer

SN - 0163-5581

IS - 2

ER -